Breaking News Instant updates and real-time market news.

BOLD

Audentes Therapeutics

$33.98

0.81 (2.44%)

07:17
05/17/18
05/17
07:17
05/17/18
07:17

Audentes Therapeutics price target raised to $40 from $37 at H.C. Wainwright

H.C. Wainwright analyst Debjit Chattopadhyay raised his price target for Audentes Therapeutics to $40 after the company presented updated data from its most advanced gene therapy AT132, for the treatment of X-linked myotubular myopathy. The analyst says that while he would have preferred a cleaner read from the ventilator support endpoint, the follow up periods could be inadequate. He expects to see continued improvements at month 12 versus the current follow up periods. Chattopadhyay views the AT132 data as encouraging and keeps a Buy rating on Audentes.

BOLD Audentes Therapeutics
$33.98

0.81 (2.44%)

02/07/18
HCWC
02/07/18
NO CHANGE
Target $37
HCWC
Buy
Pompe could have 'major impact' on Audentes valuation, says H.C. Wainwright
H.C. Wainwright analyst Debjit Chattopadhyay noted that the incidence of Pompe disease is materially higher than the diseases targeted by Audentes Therapeutics' existing clinical programs, which means the AT982 drug product is likely to have a major impact on valuation if it shows compelling clinical activity. After the company announced its selection of a clinical development candidate for its Pompe program and shared timeline expectations, Chattopadhyay reiterated his Buy rating and $37 price target on the stock.
02/12/18
MZHO
02/12/18
INITIATION
Target $26
MZHO
Neutral
Audentes Therapeutics initiated with a Neutral at Mizuho
Mizuho analyst Difei Yang started Audentes Therapeutics with a Neutral rating and $26 price target.
05/10/18
HCWC
05/10/18
NO CHANGE
HCWC
Buy
Audentes' conflicting AT342 data may give investors pause, says H.C. Wainwright
H.C. Wainwright analyst Debjit Chattopadhyay noted that preliminary data from one patient enrolled in the VALENS Phase 1/2 clinical study of AT342 is being presented at a clinical meeting and he said the "conflicting data" could give Audentes Therapeutics investors pause over the near-term. The analyst, who said he awaits clinical updates in the second half of the year, has a Buy rating on Audentes shares.
05/16/18
05/16/18
NO CHANGE

Piper remains Overweight on Audentes following 'impressive' data update
Piper Jaffray analyst Christopher Raymond kept an Overweight rating and $45 price target on Audentes Therapeutics after an "impressive" data update for the first two cohorts of XLMTM patients dosed with AT132 that Raymond believes validates the initial ASPIRO readout and de-risking for the program. The analyst is "incrementally positive" on the set-up for Audentes shares ahead of the next update in Q3.

TODAY'S FREE FLY STORIES

ROL

Rollins

$62.46

0.74 (1.20%)

, ANDV

Andeavor

$157.60

-1.41 (-0.89%)

18:30
09/25/18
09/25
18:30
09/25/18
18:30
Hot Stocks
S&P announces changes to S&P 400, 500, 600 indices »

S&P Dow Jones Indices…

ROL

Rollins

$62.46

0.74 (1.20%)

ANDV

Andeavor

$157.60

-1.41 (-0.89%)

INGN

Inogen

$258.49

5.5 (2.17%)

VNDA

Vanda Pharmaceuticals

$20.70

0.3 (1.47%)

MPC

Marathon Petroleum

$85.04

-0.78 (-0.91%)

GTX

Garrett Motion

$0.00

(0.00%)

ACET

Aceto

$2.83

-0.09 (-3.08%)

HON

Honeywell

$165.59

0.12 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 01

    Oct

  • 09

    Oct

  • 19

    Oct

  • 27

    Nov

TJX

TJX

$110.33

0.605 (0.55%)

18:27
09/25/18
09/25
18:27
09/25/18
18:27
Initiation
TJX initiated  »

TJX initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYH

Community Health

$3.41

-0.08 (-2.29%)

18:25
09/25/18
09/25
18:25
09/25/18
18:25
Hot Stocks
Breaking Hot Stocks news story on Community Health »

Community Health up 3.2%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFL

Aflac

$47.69

-0.01 (-0.02%)

18:25
09/25/18
09/25
18:25
09/25/18
18:25
Conference/Events
Aflac to hold financial analysts briefing »

Financial Analysts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

TPC

Tutor Perini

$19.55

-0.275 (-1.39%)

18:12
09/25/18
09/25
18:12
09/25/18
18:12
Hot Stocks
Tutor Perini awarded $82M aircraft maintenance contract »

Tutor Perin announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLTH

Nobilis Health

$0.95

-0.0494 (-4.94%)

18:01
09/25/18
09/25
18:01
09/25/18
18:01
Hot Stocks
Nobilis Health names Kenny Klein new CFO »

Nobilis Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

FPAY

FlexShopper

$1.16

-0.69 (-37.30%)

17:57
09/25/18
09/25
17:57
09/25/18
17:57
Syndicate
FlexShopper 10M share Secondary priced at $1.00 »

Credit Suisse acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FPAY

FlexShopper

$1.16

-0.69 (-37.30%)

17:55
09/25/18
09/25
17:55
09/25/18
17:55
Syndicate
FlexShopper 10M unit Secondary priced at $1.00 »

ThinkEquity, a division…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$84.79

0.52 (0.62%)

17:48
09/25/18
09/25
17:48
09/25/18
17:48
Hot Stocks
Nike says Jordan brand 'incredibly strong' in China »

Says relationship with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

NKE

Nike

$84.79

0.52 (0.62%)

17:45
09/25/18
09/25
17:45
09/25/18
17:45
Hot Stocks
Breaking Hot Stocks news story on Nike »

Nike says recent ad…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

CYH

Community Health

$3.41

-0.08 (-2.29%)

17:43
09/25/18
09/25
17:43
09/25/18
17:43
Hot Stocks
Community Health reaches settlement pact with DOJ over HMA probe »

Community Health Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$84.79

0.52 (0.62%)

17:39
09/25/18
09/25
17:39
09/25/18
17:39
Hot Stocks
Breaking Hot Stocks news story on Nike »

Nike sees FY19 gross…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

NKE

Nike

$84.79

0.52 (0.62%)

17:39
09/25/18
09/25
17:39
09/25/18
17:39
Earnings
Nike sees 'strong' sequential revenue growth in Q2 »

Sees Q2 gross margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

KBH

KB Home

$25.29

-0.24 (-0.94%)

17:38
09/25/18
09/25
17:38
09/25/18
17:38
Hot Stocks
KB Home CEO sees slower sales in higher priced homes »

Comments from Q3 earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MTBC

Medical Transcription Billing

$4.96

0.2 (4.20%)

17:36
09/25/18
09/25
17:36
09/25/18
17:36
Syndicate
Breaking Syndicate news story on Medical Transcription Billing »

Medical Transcription…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$84.79

0.52 (0.62%)

17:34
09/25/18
09/25
17:34
09/25/18
17:34
Hot Stocks
Breaking Hot Stocks news story on Nike »

Nike says has seen 17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

GTX

Garrett Motion

$0.00

(0.00%)

, ACET

Aceto

$2.83

-0.09 (-3.08%)

17:30
09/25/18
09/25
17:30
09/25/18
17:30
Hot Stocks
Garrett Motion to replace Aceto in S&P 600 at open on October 2 »

Honeywell (HON) is…

GTX

Garrett Motion

$0.00

(0.00%)

ACET

Aceto

$2.83

-0.09 (-3.08%)

HON

Honeywell

$165.59

0.12 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 19

    Oct

NKE

Nike

$84.79

0.52 (0.62%)

17:27
09/25/18
09/25
17:27
09/25/18
17:27
Hot Stocks
Nike says has returned to 'strong, sustainable growth' in North America »

Says facets of live story…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

RBNC

Reliant Bancorp

$25.91

-0.27 (-1.03%)

17:25
09/25/18
09/25
17:25
09/25/18
17:25
Hot Stocks
Reliant Bancorp raises quarterly cash dividend 33% from last year »

Reliant Bancorp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNDA

Vanda Pharmaceuticals

$20.70

0.3 (1.47%)

, INGN

Inogen

$258.49

5.5 (2.17%)

17:25
09/25/18
09/25
17:25
09/25/18
17:25
Hot Stocks
Breaking Hot Stocks news story on Vanda Pharmaceuticals, Inogen »

Vanda Pharmaceuticals to…

VNDA

Vanda Pharmaceuticals

$20.70

0.3 (1.47%)

INGN

Inogen

$258.49

5.5 (2.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 09

    Oct

  • 27

    Nov

INGN

Inogen

$258.49

5.5 (2.17%)

, ROL

Rollins

$62.46

0.74 (1.20%)

17:23
09/25/18
09/25
17:23
09/25/18
17:23
Hot Stocks
Breaking Hot Stocks news story on Inogen, Rollins »

Inogen to replace Rollins…

INGN

Inogen

$258.49

5.5 (2.17%)

ROL

Rollins

$62.46

0.74 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 09

    Oct

  • 27

    Nov

KBH

KB Home

$25.29

-0.24 (-0.94%)

17:20
09/25/18
09/25
17:20
09/25/18
17:20
Hot Stocks
KB Home sees FY18 housing revenue of $4.6B, low end of prior $4.6B-$4.8B view »

Sees FY18 gross margin of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

ROL

Rollins

$62.46

0.74 (1.20%)

, ANDV

Andeavor

$157.60

-1.41 (-0.89%)

17:18
09/25/18
09/25
17:18
09/25/18
17:18
Hot Stocks
Rollins to replace Andeavor in S&P 500 at open on October 1 »

S&P 500 constituent…

ROL

Rollins

$62.46

0.74 (1.20%)

ANDV

Andeavor

$157.60

-1.41 (-0.89%)

MPC

Marathon Petroleum

$85.04

-0.78 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

NKE

Nike

$84.79

0.52 (0.62%)

17:15
09/25/18
09/25
17:15
09/25/18
17:15
Hot Stocks
Nike says apparel saw 11% growth in Q1 »

Says apparel saw 11%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

NKE

Nike

$84.79

0.52 (0.62%)

17:15
09/25/18
09/25
17:15
09/25/18
17:15
Hot Stocks
Nike says apparel saw 11% growth in Q1 »

Says apparel saw 11%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.